Human Class Mu Glutathione Transferases, in Particular Isoenzyme M2-2, Catalyze Detoxication of the Dopamine Metabolite Aminochrome*

(Received for publication, October 1, 1996, and in revised form, November 20, 1996)

Juan Segura-Aguilar Dagger §, Sofia Baez , Mikael Widersten par , Christopher J. Welch ** and Bengt Mannervik par

From the Dagger  Division of Biochemistry, Department of Pharmaceutical Bioscience, the par  Department of Biochemistry, and the ** Division of Organic Pharmaceutical Chemistry, Biomedical Center, Uppsala University, S-751 23 Uppsala and the  Unit of Biochemical Toxicology, Wallenberg Laboratory, Stockholm University, S-106 91 Stockholm, Sweden

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

Human glutathione transferases (GSTs) were shown to catalyze the reductive glutathione conjugation of aminochrome (2,3-dihydroindole-5,6-dione). The class Mu enzyme GST M2-2 displayed the highest specific activity (148 µmol/min/mg), whereas GSTs A1-1, A2-2, M1-1, M3-3, and P1-1 had markedly lower activities (<1 µmol/min/mg). The product of the conjugation, with a UV spectrum exhibiting absorption peaks at 277 and 295 nm, was 4-S-glutathionyl-5,6-dihydroxyindoline as determined by NMR spectroscopy. In contrast to reduced forms of aminochrome (leucoaminochrome and o-semiquinone), 4-S-glutathionyl-5,6-dihydroxyindoline was stable in the presence of molecular oxygen, superoxide radicals, and hydrogen peroxide. However, the strongly oxidizing complex of Mn3+ and pyrophosphate oxidizes 4-S-glutathionyl-5,6-dihydroxyindoline to 4-S-glutathionylaminochrome, a new quinone derivative with an absorption peak at 620 nm. GST M2-2 (and to a lower degree, GST M1-1) prevents the formation of reactive oxygen species linked to one-electron reduction of aminochrome catalyzed by NADPH-cytochrome P450 reductase. The results suggest that the reductive conjugation of aminochrome catalyzed by GSTs, in particular GST M2-2, is an important cellular antioxidant activity preventing the formation of o-semiquinone and thereby the generation of reactive oxygen species.


INTRODUCTION

Dopamine, like other catecholamines, can be oxidized to the corresponding o-quinone (1-4). The formation of catecholamine o-quinones is followed by cyclization involving the amino group of their side chains. The reduction of aminochrome, dopachrome, noradrenochrome, and adrenochrome is accompanied by their subsequent reoxidation by oxygen, which gives rise to reactive chemical species (5-8). The oxidative conversion of dopamine into aminochrome (2,3-dihydroindole-5,6-dione) and its subsequent reduction and reoxidation by oxygen are believed to be the cause of neurodegenerative processes in the dopaminergic system (9). Degeneration of the dopaminergic neurons in the nigrostriatal system as a consequence of aminochrome activation to produce reactive chemical species has been proposed to contribute to the development of Parkinson's disease (9, 10). In addition, aminochrome-dependent neurodegeneration of the dopaminergic system in the mesolimbic system has been suggested as a contributing process in the development of schizophrenia (for reviews, see Refs. 11 and 12).

Glutathione transferases (GSTs)1 catalyze the detoxication of a variety of xenobiotics including carcinogens, environmental contaminants, anticancer agents, antibiotics, and products of oxidative processes (for review, see Ref. 13). However, the ability of GSTs to catalyze conjugation of quinones is still largely unexplored. Quinones are a widespread group of xenobiotics that may give rise to cytotoxicity, mutagenesis, and carcinogenesis (14-16). The toxic effects of quinones are exploited in certain anticancer agents. On the other hand, endogenous quinones such as vitamin K1 and ubiquinone serve important physiological functions. In addition to their well established roles, ubiquinone has been proposed to be an important antioxidant in biological membranes. The protective function is provided in the reduced hydroquinone state (17), generated by the two-electron reduction catalyzed by NAD(P)H:quinone oxidoreductase (18). To study the possibility that GSTs catalyze the conjugation and detoxication of quinones, aminochrome has been chosen as a representative of endogenous quinones of obvious pathophysiological significance. This work shows that human GSTs catalyze the formation of a glutathione conjugate of aminochrome, which is more resistant to redox cycling than the parent compound. Thus, glutathione conjugation appears to be an important mechanism for protection against oxidative stress.


EXPERIMENTAL PROCEDURES

Chemicals

Dopamine, NADH, NADPH, and GSH were purchased from Sigma.

Animals

Male Sprague-Dawley rats with body weights of ~100 g were used. The animals were kept on standard laboratory diet and starved for 24 h before being sacrificed. The animals used for NADPH-cytochrome P450 reductase purification were injected intraperitoneally with 8 mg of sodium phenobarbital once daily for 4 days.

Preparation of Enzymes

Human glutathione transferases M1-1 (allelic variant b), M2-2, M3-3, A1-1, A2-2, and P1-1 (for nomenclature, see Ref. 19) were obtained by heterologous expression in Escherichia coli and purified by affinity chromatography on S-hexylglutathione immobilized on Sepharose 4B (20). NADPH-cytochrome P450 reductase was purified from liver microsomes from phenobarbital-treated rats according to Yasukochi and Masters (21). Protein determination was performed according to the method of Bradford (22).

Synthesis of Aminochrome and Related Compounds

Oxidation of dopamine to aminochrome was performed as described previously (4). The oxidizing agent was the Mn3+-pyrophosphate complex prepared as described by Archibald and Fridovich (23). Oxidation of 4-S-glutathionyl-5,6-dihydroxyindoline to 4-S-glutathionyl-5,6-dihydroxyindole was performed as described by Mason (24). Three-hundred microliters of 12 M HCl was added to 1 ml of 300 µM 4-S-glutathionyl-5,6-dihydroxyindoline solution in 25 mM sodium phosphate, pH 6.5, to decrease the pH to 1.3. The reaction mixture was incubated for 30 min at room temperature. The absorption spectra before and after oxidation of the indoline ring to indole were recorded.

Assay Conditions

Conjugation of Aminochrome with Glutathione

The standard assay system for measuring conjugation of aminochrome with GSH catalyzed by GSTs contained 0.1 M sodium phosphate, pH 6.5, 1 mM GSH, and 300 µM aminochrome at 30 °C. The reaction was started by the addition of GST. The reaction was recorded by monitoring the decrease in aminochrome absorption at 475 nm. The reaction rate was calculated by using the extinction coefficient of aminochrome of 3058 M-1 cm-1 (4).

Aminochrome Reduction Catalyzed by NADPH-Cytochrome P450 Reductase

The assay system of 1 ml contained 50 mM Tris-Cl, pH 6.5, 0.25 M sucrose, 30 µM aminochrome, 1 mM (when present) GSH, 60 µg (when present) of GST M1-1 or 8 µg (when present) of GST M2-2, and 250 µM NADPH. The formation of aminochrome (4) was allowed to proceed for 2 min in the cuvette before the addition of GSH and NADPH. The reaction was started by the addition of GST and 5 µg of purified NADPH-cytochrome P450 reductase at 30 °C. The reaction was monitored by recording NADPH oxidation at 340 nm (using an extinction coefficient of 6220 M-1 cm-1) (4). Oxygen consumption was monitored with an oxygen electrode from Hansatech D. W. (King's Lynn, United Kingdom).

NMR Studies of the Reaction Product

For the structural analysis 300 µM aminochrome and 1 mM GSH were incubated with 100 µg of GST M1-1 in 100 ml of 0.1 M sodium phosphate, pH 6.5, for 30 min. The aqueous solution was diluted with 1-butanol and concentrated to 25 ml under reduced pressure. More 1-butanol was added, and the concentration procedure was repeated until all traces of water were removed. The resulting solution was concentrated to 0.5 ml. The residue was mixed with diethyl ether (10 ml), and acetic anhydride (0.5 ml) was added, followed by triethylamine (1 ml) and 4-dimethylaminopyridine (catalytic amount). The resultant mixture gave a clear solution after 10 min and was stirred for a further 2 h, during which time considerable darkening occurred. The reaction mixture was poured into saturated sodium hydrogen carbonate solution (50 ml), extracted with dichloromethane (5 × 50 ml), dried with sodium sulfate, and concentrated. The residue was purified on a silica gel column (0.5 × 20 cm) using a stepwise gradient of ethyl acetate in pentane (0-100%) followed by ethanol in ethyl acetate (0-30%) as eluent. The major fraction was isolated and analyzed in CDCl3 solution by NMR spectroscopy. NMR spectra were recorded at 399.78 MHz using a JEOL JNM400 spectrometer. Standard pulse sequences were used for double quantum-filtered COSY and NOESY (nuclear Overhauser enhancement spectroscopy) spectra; for the latter, mixing times were varied between 100 and 600 ms.


RESULTS

Glutathione Conjugation of Aminochrome

GSH reacts nonenzymatically with aminochrome, forming a conjugate at pH 6.5 and 30 °C (Table I). The enzymatic conjugation of aminochrome with GSH was studied with six different human isoenzymes, GSTs A1-1, A2-2, P1-1, M1-1, M2-2, and M3-3. All these GSTs were found to catalyze the conjugation of aminochrome, although major differences in the rates were found. Class Mu GSTs exhibited the highest specific activity, in particular GST M2-2 (148 µmol/min/mg of enzyme), while other GSTs had much lower specific activities (Table I). The activity of GST M2-2 with aminochrome was comparable to that with 1-chloro-2,4-dinitrobenzene, which usually is by far the most active substrate for GSTs. The conjugation of aminochrome was recorded by following the decrease in the absorbance at 475 nm, which is the typical quinone absorption peak (Fig. 1, A and B). A linear correlation between initial velocity and amount of enzyme was demonstrated with GSTs M1-1 and M2-2 (Fig. 2).

Table I.

Glutathione conjugation of aminochrome catalyzed by various human GSTs

Enzymatic activities with 1-chloro-2,4-dinitrobenzene were determined according to Habig et al. (29) and with aminochrome as described under "Experimental Procedures." The initial rates of the nonenzymatic reactions (24 ± 4 nmol/min for aminochrome) were determined under the same conditions and subtracted from the measured values.
GST CDNBa Aminochrome

µmol/min/mg µmol/min/mg
A1-1 46  ± 3 0.037  ± 0.002
A2-2 32  ± 5 0.031  ± 0.002
M1-1 96  ± 20 0.763  ± 0.090
M2-2 138  ± 5 148  ± 13
M3-3 3.4  ± 0.8 0.143  ± 0.022
P1-1 41  ± 10 0.041  ± 0.023

a  CDNB, 1-chloro-2,4-dinitrobenzene.


Fig. 1. Reductive conjugation of aminochrome with glutathione catalyzed by GSTs M1-1 and M2-2. A, catalytic effect of GST M1-1 on the reaction between 130 µM aminochrome and 1 mM GSH in 0.1 M sodium phosphate, pH 6.5. Spectra were recorded after 0 (spectrum a), 1 (spectrum b), 5 (spectrum c), and 10 (spectrum d) min. B, catalytic effect of GST M2-2 on 160 µM aminochrome and 1 mM GSH. Spectra were recorded after 0 (spectrum a) and 1 (spectrum b) min.
[View Larger Version of this Image (17K GIF file)]



Fig. 2. Formation of 4-S-glutathionyl-5,6-dihydroxyindoline as a function of the amount of GSTs M1-1 (A) and M2-2 (B). The incubation conditions are described under "Experimental Procedures."
[View Larger Version of this Image (16K GIF file)]


Characterization of the Aminochrome Conjugate

The decrease in the absorbance at 475 nm in the visible region caused by conjugation of aminochrome with GSH was also accompanied by a decrease in the absorbance of aminochrome at 298 nm in the ultraviolet region (Fig. 1). The decrease in aminochrome absorbance at 475 nm suggests that GSTs M1-1 and M2-2 catalyze a conjugation, which can be regarded as a two-electron reduction of aminochrome. The absorption spectrum of the glutathione conjugate exhibited two peaks at 277 and 295 nm. However, to determine whether the decrease in the absorbance at 475 was due to the reduction of aminochrome or was a consequence of the addition of glutathione to the carbonyl groups, a potent oxidizing agent was used to oxidize leucoaminochrome-GSH to the corresponding o-quinone. The addition of the Mn3+-pyrophosphate complex to leucoaminochrome-GSH resulted in its oxidation to aminochrome-GSH with a new absorption peak in the visible region at 620 nm, supporting the view that the addition of glutathione does not affect the o-quinone structure (Fig. 3A). In the ultraviolet region, a new peak at 310 nm was also observed (data not shown).


Fig. 3. Oxidation of 4-S-glutathionyl-5,6-dihydroxyindoline by the Mn3+-pyrophosphate complex (A) and stability of the conjugate under aerobic conditions (B). A, 102 µM aminochrome (spectrum a) was reduced with GST M1-1 (60 µg) to 4-S-glutathionyl-5,6-dihydroxyindoline (spectrum b) in the presence of 1 mM GSH. 4-S-Glutathionyl-5,6-dihydroxyindoline was oxidized to 4-S-glutathionylaminochrome by the addition of 1 mM Mn3+-pyrophosphate complex. B, 80 µM aminochrome (spectrum a) was reduced with 500 µM GSH in the presence of 60 µg of GST M1-1, and the absorption spectra were registered 10 (spectrum b), 30 (spectrum c), and 60 (spectrum d) min after reduction.
[View Larger Version of this Image (17K GIF file)]


NMR studies were performed to determine the structure of the glutathione conjugate. However, direct NMR spectroscopic observation of the product was not possible since concentration of the reaction solution resulted in polymerization. Azeotropic removal of the water with 1-butanol under reduced pressure followed by acylation of the concentrate afforded the crude tetraacetate (Fig. 4A). NMR spectroscopy of the product showed coupled doublets at 6.64 and 7.4 ppm, consistent with oxidation of the dihydroxyindoline followed by isomerization to the corresponding indole, probably occurring during the workup procedure. The structure of the product was confirmed by the presence of nuclear Overhauser effect correlations between H-7 and two acetate groups and between H-3 and the CH2 of the cysteine residue (Fig. 4B). We found that the structure of the acylated conjugate was 4-S-[(acetylglutamoyl)-N-cysteinyl-N-glycinyl]-5,6-diacetoxyindole: 1H NMR delta  (ppm) 1.88 (2H, dt, J = 7.0, 8.0 Hz, beta -CH2-Glu), 2.20-2.30 (14H, m, gamma -CH2-Glu, CH3-acetyl), 3.08 (2H, m, CH2-Cys), 3.40-3.44 (2H, m (AB), CH2-Gly), 3.76 (1H, t, J = 8.0 Hz, CH-Glu), 4.16 (1H, m, CH-Cys), 6.64 (1H, d, J = 3.0 Hz, H-3), 7.10, (1H, s, H-7), and 7.45 (1H, d, J = 3.0 Hz, H-2). The data obtained were consistent with the data for the nonacylated compound previously isolated (25). Therefore, we conclude that the structure of the nonacylated conjugate is 4-S-glutathionyl-5,6-dihydroxyindole. However, 4-S-glutathionyl-5,6-dihydroxyindole has been reported to have two peaks in the ultraviolet region at 295 and 307 nm (25), while the product of glutathione conjugation of aminochrome exhibited two different peaks at 277 and 295 nm. The possibility that the two peaks of the conjugate at 277 and 295 nm change to 295 and 307 nm as a consequence of oxidation of the indoline ring to indole during acylation of the product before NMR analysis was studied. Therefore, the spectrum of the conjugate product was compared with the spectrum obtained after oxidation of indoline to indole under acid catalysis according to Mason (24). The two peaks of the conjugate at 277 and 295 nm did change after acid catalysis to 295 and 307 nm, a result in agreement with the data reported by D'Ischia et al. (25) (data not shown). Therefore, we conclude that the structure of the conjugate is 4-S-glutathionyl-5,6-dihydroxyindoline, which was subsequently oxidized to the indole derivative during the workup and acylation procedures.


Fig. 4. Analysis of the aminochrome-GSH conjugate. A, acetylation of 4-S-glutathionyl-5,6-dihydroxyindoline to block the free hydroxyl and amino groups accompanied by oxidation and isomerization of indoline to indole. Acetylation was performed as described under "Experimental Procedures." B, nuclear Overhauser effect correlations used for structural assignment of the indole-glutathione conjugate by NMR analysis.
[View Larger Version of this Image (17K GIF file)]


An important question was whether the glutathione conjugate could be oxidized by molecular oxygen like reduced forms of aminochrome (o-semiquinone and o-hydroquinone). Fig. 3B shows the absorption spectra of the aminochrome (spectrum a) and 4-S-glutathionyl-5,6-dihydroxyindoline at 15, 30, and 60 min (spectra b-d) in the visible region. However, no increase in the absorbance at 620 nm, where the o-quinone has an absorption maximum, was observed even after 60 min (spectrum d), suggesting that 4-S-glutathionyl-5,6-dihydroxyindoline is stable in the presence of oxygen. These results were in agreement with the fact that no oxygen consumption was measurable during conjugation of aminochrome to 4-S-glutathionyl-5,6-dihydroxyindoline or after completion of the reaction (data not shown).

Superoxide radicals (Obardot 2) have been reported to play a major role in the reoxidation of leucoaminochrome produced by the NAD(P)H:quinone oxidoreductase-catalyzed reduction of aminochrome (9). Therefore, we have studied the possibility that superoxide radicals may catalyze the autoxidation of 4-S-glutathionyl-5,6-dihydroxyindoline by using xanthine oxidase and hypoxanthine to produce superoxide radicals. However, no oxidation of 4-S-glutathionyl-5,6-dihydroxyindoline in the presence of superoxide radicals was observed. The possibility that other biological oxidizing agents such as H2O2 may oxidize the conjugate was also studied. However, no autoxidation of 4-S-glutathionyl-5,6-dihydroxyindoline was observed in the presence of H2O2 (data not shown).

GSTs M2-2 and M1-1 Compete with NADPH-Cytochrome P450 Reductase in the Reduction of Aminochrome

One-electron reduction of aminochrome catalyzed by enzymes such as NADPH-cytochrome P450 reductase has been postulated to be responsible for the formation of reactive oxygen species that promote neurodegenerative processes in the dopaminergic system (9). Therefore, it is of interest to know whether GST M2-2 and other GSTs may compete with NADPH-cytochrome P450 reductase in the metabolism of aminochrome. Fig. 5 shows that the reduction of aminochrome by NADPH-cytochrome P450 reductase is accompanied by a constant rate of NADPH oxidation (21 nmol of NADPH/min) recorded at 340 nm. The addition of 1 mM GSH to the incubation mixture resulted in 31% inhibition of autoxidation. However, the addition of GST M1-1 (60 µg/ml) to the incubation mixture resulted in a strong inhibition (94%) of NADPH oxidation. The inhibitory effect of GST M2-2 (8 µg/ml) was even more marked since the addition of a smaller amount of this enzyme resulted in 98% inhibition of NADPH oxidation. A strong inhibition of oxygen consumption was also observed when GST M1-1 was added to the incubation mixture. It is of significance that no increase in the o-quinone absorbance peak at 620 nm was observed when GSH and/or glutathione transferase was added to the incubation mixture (data not shown).


Fig. 5. Glutathione transferases M1-1 (A) and M2-2 (B) compete with NADPH-cytochrome P450 reductase in the reduction of aminochrome. The incubations conditions are described under "Experimental Procedures." The values are the means ± S.D. of three experiments.
[View Larger Version of this Image (20K GIF file)]



DISCUSSION

Aminochrome is the product of the oxidation of dopamine to o-quinone followed by cyclization of its aminoethyl chain at physiological pH. It has been proposed that the formation of aminochrome and the subsequent generation of reactive oxygen species are involved in the neurodegenerative processes that occur in dopaminergic neurons in the nigrostriatal system in Parkinson's disease (9, 10) and in the mesolimbic system in schizophrenia (11, 12).

The results presented in this paper demonstrate that human GSTs catalyze the reductive conjugation of aminochrome to 4-S-glutathionyl-5,6-dihydroxyindoline (Scheme 1). The NMR studies showed that the structure of the acetylated derivative produced for analysis was 4-S-[(acetylglutamoyl)-N-cysteinyl-N-glycinyl]-5,6-diacetoxyindole. We conclude that the structure of the product of the GST-catalyzed reaction is 4-S-glutathionyl-5,6-dihydroxyindoline since the spectrum of the corresponding oxidized (nonacetylated) compound, 4-S-glutathionyl-5,6-dihydroxyindole, is not the same as the conjugate (4-S-glutathionyl-5,6-dihydroxyindoline) enzymatically produced. The two peaks of 4-S-glutathionylleucoaminochrome at 278 and 295 nm are shifted to 295 and 307 nm in 4-S-glutathionyl-5,6-dihydroxyindole due to oxidation of the dihydroxyindoline followed by acid-catalyzed isomerization to indole during the workup and acylation procedures required for NMR analysis.


[View Larger Version of this Image (8K GIF file)]

Scheme 1.

GSTs are known to have broad and overlapping substrate specificities, but only a few of their numerous substrates are so markedly preferentially used by one isoenzyme as aminochrome. With this substrate, GST M2-2 has a specific activity >200-fold above that of any other GST (Table I). Another example is 2-cyano-1,3-dimethyl-1-nitrosoguanidine, for which GST M2-2 is also the most active enzyme by almost 2 orders of magnitude (26). The finding that aminochrome is an excellent GST substrate extends the number of physiologically occurring compounds that serve as substrates for GSTs. Aminochrome is a product of oxidative metabolism, like many other pathophysiologically relevant GST substrates such as alkenals and hydroperoxides generated by biological oxidations and radical reactions (27).

NADPH-cytochrome P450 reductase and NAD(P)H:quinone oxidoreductase catalyze one- and two-electron reduction of aminochrome to o-semiquinone and leucoaminochrome (o-hydroquinone), respectively. These products are oxidized by O2, yielding reactive oxygen species. However, a major difference in the rate of oxidation of o-semiquinone and o-hydroquinone forms has been observed (4, 9). The autoxidation of o-semiquinone is too fast to be recorded by conventional steady-state kinetics, whereas the autoxidation of the o-hydroquinone can readily be monitored by the decrease in the quinone absorption peak at 475 nm. The lability of o-semiquinone and leucoaminochrome in the presence of oxygen contrasts with the chemical stability of 4-S-glutathionyl-5,6-dihydroxyindoline since no oxidation was observed during conjugation or after the completion of the reaction. The reactivity of 4-S-glutathionyl-5,6-dihydroxyindoline was found to be completely different from that of leucoaminochrome and o-semiquinone. Molecular oxygen (O2) is mainly responsible for oxidation of o-semiquinone (91% of the total oxygen-dependent autoxidation) (9), while superoxide radicals are mainly responsible for oxidation of the leucoaminochrome (89% of the total oxygen-dependent autoxidation) (4, 9). However, superoxide radicals, hydrogen peroxide, and molecular oxygen are not able to oxidize 4-S-glutathionyl-5,6-dihydroxyindoline under the conditions investigated.

It seems reasonable to consider glutathione conjugation of aminochrome as a reaction terminating any possible redox cycling since it prevents the formation of reactive oxygen species during one- or two-electron reduction of aminochrome. It is obvious that a very small amount of aminochrome can give rise to a large production of reactive oxygen species due the redox cycling properties of aminochrome, emphasizing the importance of the glutathione conjugation. Our results show that GST M2-2, as well as GST M1-1, by a competing conjugation reaction prevents autoxidation otherwise elicited by the reduction of aminochrome catalyzed by NADPH-cytochrome P450 reductase (Fig. 5). One-electron reduction of aminochrome catalyzed by NADPH-cytochrome P450 reductase has been postulated to be the mechanism of formation of reactive oxygen species, which can cause neurodegeneration that in the nigrostriatal system may result in Parkinson's disease or in the mesolimbic system in schizophrenia (9).

The glutathione conjugation catalyzed by class Mu GSTs seems to be the most important of the reported antioxidant reactions related to aminochrome metabolism since this reaction prevents the redox cycling between oxidized and reduced forms of aminochrome as a consequence of the chemical stability of 4-S-glutathionyl-5,6-dihydroxyindoline. NAD(P)H:quinone oxidoreductase has also been postulated to provide an important cellular defense against formation of reactive oxygen species since the reaction catalyzed by NAD(P)H:quinone oxidoreductase competes with one-electron donors such as NADPH-cytochrome P450 reductase for the reduction of aminochrome to leucoaminochrome (4). However, the antioxidant role of NAD(P)H:quinone oxidoreductase is dependent on the presence of superoxide dismutase, catalase, or GSH peroxidase, which inhibit leucoaminochrome autoxidation, or on the action of conjugation enzymes such as sulfotransferase or catechol ortho-methyltransferase. It seems plausible that human subjects with low expression or lack of the genes coding for NAD(P)H:quinone oxidoreductase, GST M1-1, and/or GST M2-2 will be at higher risk for neurodegeneration of the dopaminergic nigrostriatal or mesolimbic system, which may result in the development of Parkinson's disease and schizophrenia, respectively.

We conclude that GST M2-2 efficiently catalyzes the conjugation of aminochrome, thus preventing the formation of reactive oxygen species. Other GSTs, such as the class Mu enzymes GST M1-1 and GST M3-3, also promote this conjugation reaction, albeit with much lower catalytic activities. We cannot disregard the possibility that other enzymes not yet tested also play a role in detoxication of aminochrome. An example is GST M5-5, which has been cloned from a cDNA library from the frontal cortex of human brain (28). To establish the physiological relevance of the GST activity to neurodegenerative diseases such as Parkinson's disease and schizophrenia, it is necessary to explore the regional distribution of GST M2-2 and other class Mu GSTs in the brain and in the dopaminergic system.


FOOTNOTES

*   This work was supported by the Tore Nilson Foundation of Medical Research, the Swedish Natural Science Research Council, and the Swedish Cancer Society. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed: Div. of Biochemistry, Dept. of Pharmaceutical Bioscience, BMC, Box 578, S-751 23 Uppsala, Sweden. Tel.: 46-18-174281; Fax: 46-18-558778; E-mail: Juan.SeguraAguilar{at}farmbio.uu.se.
1    The abbreviation used is: GSTs, glutathione transferases.

REFERENCES

  1. Graham, D. G. (1978) Mol. Pharmacol. 14, 633-643 [Abstract]
  2. Hawley, M. D., Tatawawadi, S. V., Piekarski, S., and Adams, R. N. (1967) J. Am. Chem. Soc. 89, 447-450 [Medline] [Order article via Infotrieve]
  3. Harrison, W. H., Whisler, W. W., and Hill, B. J. (1968) Biochemistry 7, 3089-3093 [Medline] [Order article via Infotrieve]
  4. Segura-Aguilar, J., and Lind, C. (1989) Chem. Biol. Interact. 72, 309-324 [Medline] [Order article via Infotrieve]
  5. Baez, S., Linderson, Y., and Segura-Aguilar, J. (1994) Chem. Biol. Interact. 93, 103-116 [Medline] [Order article via Infotrieve]
  6. Linderson, Y., Baez, S., and Segura-Aguilar, J. (1994) Biochim. Biophys. Acta 1200, 197-204 [Medline] [Order article via Infotrieve]
  7. Baez, S., and Segura-Aguilar, J. (1994) Redox Report 1, 65-70
  8. Baez, S., and Segura-Aguilar, J. (1995) Biochem. Mol. Med. 56, 37-44 [CrossRef][Medline] [Order article via Infotrieve]
  9. Baez, S., Linderson, Y., and Segura-Aguilar, J. (1995) Biochem. Mol. Med. 54, 12-18 [CrossRef][Medline] [Order article via Infotrieve]
  10. Graham, D. G. (1984) Neurotoxicology (Little Rock) 5, 83-96 [Medline] [Order article via Infotrieve]
  11. Cadet, J. L., and Kahler, L. A. (1994) Neurosci. Biobehav. Rev. 18, 457-467 [CrossRef][Medline] [Order article via Infotrieve]
  12. Smythies, J. (1996) Proc. R. Soc. Lond. B Biol. Sci. 263, 487-489 [Medline] [Order article via Infotrieve]
  13. Hayes, J. D., and Pulford, D. J. (1995) Crit. Rev. Biochem. Mol. Biol. 30, 445-600 [Abstract]
  14. Segura-Aguilar, J., Jönsson, K., Tidefelt, U., and Paul, C. (1992) Leuk. Res. 16, 631-637 [Medline] [Order article via Infotrieve]
  15. Segura-Aguilar, J., Cortez-Vizcaino, V., Llombart-Bosch, A., Ernster, L., Monsalve, E., and Romero, F. J. (1990) Carcinogenesis 11, 1727-1732 [Abstract]
  16. Segura-Aguilar, J., Cremades, A., Llombart-Bosch, A., Monsalve, E., Ernster, L., and Romero, F. J. (1994) Carcinogenesis 15, 1631-1636 [Abstract]
  17. Beyer, R. E. (1992) Biochem. Cell Biol. 70, 390-403 [Medline] [Order article via Infotrieve]
  18. Beyer, R. E., Segura-Aguilar, J., Di Bernardo, S., Cavazzoni, M., Fato, R., Fiorentini, D., Cristina Galli, M., Setti, M., Landi, L., and Lenaz, G. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 2528-2532 [Abstract/Free Full Text]
  19. Mannervik, B., Awasthi, Y. C., Board, P. G., Hayes, J. D., Di Ilio, C., Ketterer, B., Listowsky, I., Morgenstern, R., Muramatsu, M., Pearson, W. R., Pickett, C. B., Sato, K., Widersten, M., and Wolf, C. R. (1992) Biochem. J. 282, 305-306 [Medline] [Order article via Infotrieve]
  20. Mannervik, B., and Guthenberg, C. (1981) Methods Enzymol. 77, 231-235 [Medline] [Order article via Infotrieve]
  21. Yasukochi, Y., and Masters, B. S. S. (1976) J. Biol. Chem. 251, 5337-5344 [Abstract]
  22. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  23. Archibald, F. S., and Fridovich, I. (1982) Arch. Biochem. Biophys. 214, 452-463 [Medline] [Order article via Infotrieve]
  24. Mason, H. S. (1948) J. Biol. Chem. 172, 83-99 [Free Full Text]
  25. D'Ischia, A., Napolitano, A., and Prota, G. (1987) Tetrahedron 43, 5351-5356 [CrossRef]
  26. Mannervik, B., and Widersten, M. (1995) in Advances in Drug Metabolism in Man (Pacifici, G. M., and Fracchia, G. N., eds), pp. 407-459, European Commission, Luxembourg, Belgium
  27. Berhane, K., Widersten, M., Engström, Å., Kozarich, J. W., and Mannervik, B. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1480-1484 [Abstract]
  28. Takahashi, Y., Campbell, E. A., Hirata, Y., Takayama, T., and Listowsky, I. (1993) J. Biol. Chem. 268, 8893-8898 [Abstract/Free Full Text]
  29. Habig, W. H., Pabst, M. J., and Jakoby, W. B. (1974) J. Biol. Chem. 249, 7130-7139 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.